These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24486418)

  • 1. Synthesis and 3D-QSAR study of 1,4-dihydropyridine derivatives as MDR cancer reverters.
    Radadiya A; Khedkar V; Bavishi A; Vala H; Thakrar S; Bhavsar D; Shah A; Coutinho E
    Eur J Med Chem; 2014 Mar; 74():375-87. PubMed ID: 24486418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities.
    Mehdipour AR; Javidnia K; Hemmateenejad B; Amirghofran Z; Miri R
    Chem Biol Drug Des; 2007 Oct; 70(4):337-46. PubMed ID: 17937779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.
    Globisch C; Pajeva IK; Wiese M
    Bioorg Med Chem; 2006 Mar; 14(5):1588-98. PubMed ID: 16307883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
    Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
    J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties.
    Baumert C; Günthel M; Krawczyk S; Hemmer M; Wersig T; Langner A; Molnár J; Lage H; Hilgeroth A
    Bioorg Med Chem; 2013 Jan; 21(1):166-77. PubMed ID: 23199479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
    Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
    Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.
    Fleischer R; Wiese M
    J Med Chem; 2003 Nov; 46(23):4988-5004. PubMed ID: 14584949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
    Miri R; Mehdipour A
    Bioorg Med Chem; 2008 Sep; 16(18):8329-34. PubMed ID: 18701304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines.
    Firuzi O; Javidnia K; Mansourabadi E; Saso L; Mehdipour AR; Miri R
    Arch Pharm Res; 2013 Nov; 36(11):1392-402. PubMed ID: 23674129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches.
    Tsakovska IM; Pajeva IK
    SAR QSAR Environ Res; 2002; 13(3-4):487-98. PubMed ID: 12184389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells.
    Tsakovska IM
    Bioorg Med Chem; 2003 Jul; 11(13):2889-99. PubMed ID: 12788359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5-diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.
    Shah A; Gaveriya H; Motohashi N; Kawase M; Saito S; Sakagami H; Satoh K; Tada Y; Solymosi A; Walfard K; Molnar J
    Anticancer Res; 2000; 20(1A):373-7. PubMed ID: 10769682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
    Gunda SK; Narasimha SK; Shaik M
    Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
    Khunt RC; Khedkar VM; Coutinho EC
    Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors.
    Sirisha K; Shekhar MC; Umasankar K; Mahendar P; Sadanandam A; Achaiah G; Reddy VM
    Bioorg Med Chem; 2011 May; 19(10):3249-54. PubMed ID: 21530277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship and quantitative structure-pharmacokinetics relationship of 1,4-dihydropyridines and pyridines as multidrug resistance modulators.
    Zhou XF; Shao Q; Coburn RA; Morris ME
    Pharm Res; 2005 Dec; 22(12):1989-96. PubMed ID: 16158213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridines and multidrug resistance: previous attempts, present state, and future trends.
    Zarrin A; Mehdipour AR; Miri R
    Chem Biol Drug Des; 2010 Nov; 76(5):369-81. PubMed ID: 20925689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.